Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Michel

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Plos One|July 27, 2021
Risk factors for poorer health literacy in patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Clinics and Research in Hepatology and Gastroenterology|February 6, 2022
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept studyAngelo Armandi, Helena Bespaljko, Alexander Mang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 22, 2022
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIVMaurice Michel, Alisha Wahl, Malena Anders, et al.
Future Oncology (London, England)|May 17, 2021
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerMarkus Moehler, Maurice Michel, Alexander Stein, et al.
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Plos One|July 27, 2021
Risk factors for poorer health literacy in patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Clinics and Research in Hepatology and Gastroenterology|February 6, 2022
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept studyAngelo Armandi, Helena Bespaljko, Alexander Mang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 22, 2022
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIVMaurice Michel, Alisha Wahl, Malena Anders, et al.
Future Oncology (London, England)|May 17, 2021
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerMarkus Moehler, Maurice Michel, Alexander Stein, et al.
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Pageof 7